Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) Other Current Assets

2.8 / 5 stars · 68/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Other Current Assets

LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Other Current Assets of $6.19 million as of 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:OtherAssetsCurrent · last filed 2026-08-07

  • 2026-06-30: Other Assets, Current $6.19M.
  • 2026-03-31: Other Assets, Current $5.79M.
  • 2025-12-31: Other Assets, Current $5.79M.
  • 2025-09-30: Other Assets, Current $6.99M.
Period endOther Assets, CurrentOther Assets, Current as first filed
2026-06-30$6.19M
10-Q · filed 2026-08-07
2026-03-31$5.79M
10-Q · filed 2026-05-08
2025-12-31$5.79M
10-Q · filed 2026-08-07
2025-09-30$6.99M
10-Q · filed 2025-11-07
2025-06-30$4.82M
10-Q · filed 2025-08-08
2025-03-31$13.29M
10-Q · filed 2025-05-09
2024-12-31$8.81M
10-K · filed 2026-02-27
$16.90M
10-K · filed 2025-02-28
2024-09-30$19.74M
10-Q · filed 2024-11-08
2024-06-30$7.12M
10-Q · filed 2024-08-07
2024-03-31$7.31M
10-Q · filed 2024-05-08
2023-12-31$2.66M
10-K · filed 2025-02-28
2023-09-30$2.10M
10-Q · filed 2023-11-09
2023-06-30$2.77M
10-Q · filed 2023-08-09
2023-03-31$2.33M
10-Q · filed 2023-05-08
2022-12-31$2.27M
10-K · filed 2024-02-29
$3.40M
10-K · filed 2023-02-28
2022-09-30$10.75M
10-Q · filed 2022-11-08
2022-06-30$7.80M
10-Q · filed 2022-08-09
2022-03-31$4.66M
10-Q · filed 2022-05-09
2021-12-31$3.57M
10-K · filed 2023-02-28
$4.67M
10-K · filed 2022-02-28
2021-09-30$5.16M
10-Q · filed 2021-11-09
2021-06-30$6.27M
10-Q · filed 2021-08-03
2021-03-31$5.71M
10-Q · filed 2021-05-06
2020-12-31$3.82M
10-K · filed 2022-02-28
2020-09-30$3.19M
10-Q · filed 2020-11-06
2020-06-30$5.49M
10-Q · filed 2020-08-07
2020-03-31$4.94M
10-Q · filed 2020-05-08
2019-12-31$4.73M
10-K · filed 2021-02-24
2019-09-30$5.04M
10-Q · filed 2019-11-08
2019-06-30$5.67M
10-Q · filed 2019-08-08
2019-03-31$9.23M
10-Q · filed 2019-05-09
2018-12-31$11.02M
10-K · filed 2020-02-27
$20.42M
10-K · filed 2019-02-28
2018-09-30$25.34M
10-Q · filed 2018-11-08
2018-06-30$12.82M
10-Q · filed 2018-08-08
2018-03-31$5.65M
10-Q · filed 2018-05-09
2017-12-31$1.51M
10-K · filed 2019-02-28
2017-09-30$1.11M
10-Q · filed 2017-11-09
2017-06-30$1.07M
10-Q · filed 2017-08-09
2017-03-31$641.00K
10-Q · filed 2017-05-09
2016-12-31$2.17M
10-K · filed 2018-03-01
2016-09-30$2.76M
10-Q · filed 2016-11-14
2016-06-30$2.60M
10-Q · filed 2016-11-14
2016-03-31$1.56M
10-Q · filed 2016-11-14
2015-12-31$1.91M
10-K · filed 2017-02-28
2015-09-30$1.78M
10-Q · filed 2015-11-09
2015-06-30$1.80M
10-Q · filed 2015-08-05
2015-03-31$926.00K
10-Q · filed 2015-05-11
2014-12-31$1.84M
10-K · filed 2016-11-14
$959.00K
10-K · filed 2014-12-01
2014-09-30$1.60M
10-Q · filed 2014-10-31
2014-06-30$1.12M
10-Q · filed 2014-08-05
2014-03-31$841.00K
10-Q · filed 2014-05-07
2013-12-31$959.00K
10-K · filed 2015-02-23
2013-09-30$1.51M
10-Q · filed 2013-11-08
2013-06-30$1.21M
10-Q · filed 2013-08-01
2013-03-31$986.00K
10-Q · filed 2013-05-08
2012-12-31$829.00K
10-K/A · filed 2014-12-12
2012-09-30$1.01M
10-Q · filed 2012-11-14
2012-06-30$2.02M
10-Q/A · filed 2012-11-14
2012-03-31$2.78M
10-Q/A · filed 2012-11-14
2011-12-31$1.34M
10-K · filed 2013-03-14
2011-09-30$1.66M
10-Q/A · filed 2012-02-10
2011-06-30$1.87M
10-Q/A · filed 2012-02-10
2010-12-31$720.00K
10-K/A · filed 2012-11-14